Switch to:
Cascadian Therapeutics Inc (NAS:CASC)
Sale Of Investment
$91.51 Mil (TTM As of Jun. 2016)

Cascadian Therapeutics Inc's sale of investment for the three months ended in Jun. 2016 was $18.36 Mil. It means Cascadian Therapeutics Inc gained $18.36 Mil from selling investments. Cascadian Therapeutics Inc's sale of investment for the trailing twelve months (TTM) ended in Jun. 2016 was $91.51 Mil.

Compared with last quarter ($14.10 Mil in Mar. 2016 ), Cascadian Therapeutics Inc gained more money from selling investments in Jun. 2016 ($18.36 Mil).


Definition

Sale of Investments represents cash inflow on the sale of investments in securities.

Cascadian Therapeutics Inc SaleOfInvestment for the trailing twelve months (TTM) ended in Jun. 2016 was 36.036 (Sep. 2015 ) + 23.006 (Dec. 2015 ) + 14.104 (Mar. 2016 ) + 18.362 (Jun. 2016 ) = $91.51 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Purchase of Investment, Cash Flow from Investing


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Cascadian Therapeutics Inc Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
SaleOfInvestment 43.2642.6634.251.8820.2156.6864.5268.3271.8686.03

Cascadian Therapeutics Inc Quarterly Data

Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16
SaleOfInvestment 12.0815.1112.6632.0114.6512.3436.0423.0114.1018.36
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK